Kanu, N;
Cerone, MA;
Goh, G;
Zalmas, L-P;
Bartkova, J;
Dietzen, M;
McGranahan, N;
... Swanton, C; + view all
(2016)
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
Genome Biology
, 17
, Article 185. 10.1186/s13059-016-1042-9.
Preview |
Text
McGranahan_art%3A10.1186%2Fs13059-016-1042-9.pdf - Published Version Download (3MB) | Preview |
Abstract
BACKGROUND: The APOBEC3 family of cytidine deaminases mutate the cancer genome in a range of cancer types. Although many studies have documented the downstream effects of APOBEC3 activity through next-generation sequencing, less is known about their upstream regulation. In this study, we sought to identify a molecular basis for APOBEC3 expression and activation. RESULTS: HER2 amplification and PTEN loss promote DNA replication stress and APOBEC3B activity in vitro and correlate with APOBEC3 mutagenesis in vivo. HER2-enriched breast carcinomas display evidence of elevated levels of replication stress-associated DNA damage in vivo. Chemical and cytotoxic induction of replication stress, through aphidicolin, gemcitabine, camptothecin or hydroxyurea exposure, activates transcription of APOBEC3B via an ATR/Chk1-dependent pathway in vitro. APOBEC3B activation can be attenuated through repression of oncogenic signalling, small molecule inhibition of receptor tyrosine kinase signalling and alleviation of replication stress through nucleoside supplementation. CONCLUSION: These data link oncogene, loss of tumour suppressor gene and drug-induced replication stress with APOBEC3B activity, providing new insights into how cytidine deaminase-induced mutagenesis might be activated in tumourigenesis and limited therapeutically.
Type: | Article |
---|---|
Title: | DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1186/s13059-016-1042-9 |
Publisher version: | http://dx.doi.org/10.1186/s13059-016-1042-9 |
Language: | English |
Additional information: | © 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
Keywords: | Science & Technology, Life Sciences & Biomedicine, Biotechnology & Applied Microbiology, Genetics & Heredity, Apobec, Genomic Instability, Replication Stress, Somatic Mutation, Multiple Human Cancers, Cytidine Deaminase, Mutational Processes, Genomic Instability, Chk1 Inhibitor, Lung-Cancer, Evolution, Repair, Tumorigenesis, Activation |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology |
URI: | https://discovery.ucl.ac.uk/id/eprint/1545874 |
Archive Staff Only
View Item |